Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer

Area of Science:

• Immunology
• Cellular Biology
• Pathology

Background:

• Inflammation is a local cellular response to injury or infection, involving innate immune cells and cytokine/chemokine production.
• A balance between pro-inflammatory (TNF-α, IL-6, IL-1) and anti-inflammatory (IL-10, TGF-β) mediators is crucial for normal resolution and healing.
• Systemic inflammation, driven by factors like IL-6, can indicate disease severity and prognosis, with chronic smoldering inflammation linked to various pathologies.

Purpose of the Study:

• To differentiate between beneficial and detrimental inflammatory processes.
• To highlight the role of inflammation in immune responses, disease development, and therapeutic outcomes.
• To emphasize the need for dynamic monitoring of inflammation for precision medicine.

Main Methods:

• Review of cellular and molecular mechanisms of normal and pathological inflammation.
• Analysis of the role of cytokines and chemokines in immune responses and disease.
• Discussion of the implications of inflammation in immunotherapy and precision medicine.

Main Results:

• Normal inflammation initiates adaptive immunity and enhances immunotherapy effectiveness.
• Dysregulated or chronic inflammation contributes to diseases like cancer and autoimmune disorders.
• Severe inflammation, such as in septic shock, correlates with poor prognosis.

Conclusions:

• Monitoring dynamic inflammatory processes is essential for advancing precision medicine in infections and cancer.
• Balancing inflammatory responses is critical for effective immune function and therapeutic success.
• Understanding the dual nature of inflammation (beneficial vs. detrimental) is vital for clinical applications.